The value of vaccination
- PMID: 21120715
- DOI: 10.1007/978-1-4419-7185-2_1
The value of vaccination
Abstract
Vaccination is most often studied from a scientific, clinical, or epidemiological perspective, and rightly so, for vaccines are meant to improve health outcomes. But these are not the only lenses through which the effects of vaccination programs can be understood. This chapter provides an economic perspective on vaccination programs, detailing in particular a new line of inquiry that makes a case for the importance of vaccination to achieving national economic aims. Research has shown that national spending on childhood vaccination programs does more than just reduce morbidity and mortality in a country: it also promotes national economic growth and poverty reduction. The chapter begins with a look at recent research that demonstrates powerful links that run from population health to economic well-being. Second, it discusses how knowledge of the economic benefits of health fundamentally transforms how we understand the value of vaccination. And third, it provides evidence for the scale of the returns that countries receive when they invest in immunization programs - returns that have not been fully captured by traditional economic analyses.
Similar articles
-
[Global infant mortality declines further].Kinderkrankenschwester. 2013 Dec;32(12):476-7. Kinderkrankenschwester. 2013. PMID: 24416862 German. No abstract available.
-
Recent trends in global immunisation.Adv Exp Med Biol. 2011;697:9-16. doi: 10.1007/978-1-4419-7185-2_2. Adv Exp Med Biol. 2011. PMID: 21120716 No abstract available.
-
New advances in typhoid Fever vaccination strategies.Adv Exp Med Biol. 2011;697:17-39. doi: 10.1007/978-1-4419-7185-2_3. Adv Exp Med Biol. 2011. PMID: 21120717 Review. No abstract available.
-
Healthy life expectancy for 187 countries, 1990-2010: a systematic analysis for the Global Burden Disease Study 2010.Lancet. 2012 Dec 15;380(9859):2144-62. doi: 10.1016/S0140-6736(12)61690-0. Lancet. 2012. PMID: 23245606
-
Technologies for global health.Lancet. 2012 Aug 4;380(9840):507-35. doi: 10.1016/S0140-6736(12)61127-1. Epub 2012 Aug 1. Lancet. 2012. PMID: 22857974 Review. No abstract available.
Cited by
-
[Health Technology Assessment: a value-based tool for the evaluation of healthcare technologies. Reassessment of the cell-culture-derived quadrivalent influenza vaccine: Flucelvax Tetra® 2.0].J Prev Med Hyg. 2023 Mar 2;63(4 Suppl 1):E1-E140. doi: 10.15167/2421-4248/jpmh2022.63.4s1. eCollection 2022 Dec. J Prev Med Hyg. 2023. PMID: 37034835 Free PMC article. Italian. No abstract available.
-
Advances in childhood immunisation in South Africa: where to now? Programme managers' views and evidence from systematic reviews.BMC Public Health. 2012 Jul 31;12:578. doi: 10.1186/1471-2458-12-578. BMC Public Health. 2012. PMID: 22849711 Free PMC article. Review.
-
Return on Investment (ROI) of Three Vaccination Programmes in Italy: HPV at 12 Years, Herpes Zoster in Adults, and Influenza in the Elderly.Vaccines (Basel). 2023 Apr 30;11(5):924. doi: 10.3390/vaccines11050924. Vaccines (Basel). 2023. PMID: 37243028 Free PMC article.
-
Five-year experience of African Vaccination Week implemented by the WHO Regional Office.J Immunol Sci. 2018 Aug 2;Suppl(2):10-16. J Immunol Sci. 2018. PMID: 30687850 Free PMC article.
-
Public trust and vaccine acceptance--international perspectives.Hum Vaccin Immunother. 2013 Aug;9(8):1774-8. doi: 10.4161/hv.24961. Epub 2013 Jun 3. Hum Vaccin Immunother. 2013. PMID: 23733039 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical